参考文献/References:
[1] 叶超,陈婧,刘向春,等.膝骨关节炎不同证候患者核因子-κB、影像学特点及其与证候程度间的相关性研究[J].中华中医药杂志,2020,35(10):5200-5202.
[2] 中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[3] 帖小佳,郑如庚,赵梦,等.中国中老年人膝关节骨关节炎患病率的Meta分析[J].中国组织工程研究,2018,22(4):650-656.
[4] 鄢丹,刘娟,王爱婷,等.基于循证医学证据探讨中医药优势病种作用机制的研究思路[J].中国中药杂志,2018,43(13):2633-2638.
[5] 荣兵,李建,贾峻,等.独活寄生汤治疗肝肾亏虚型膝骨关节炎患者临床疗效及关节液代谢组学变化[J].中国实验方剂学杂志,2017,23(23):159-165.
[6] 张延杰,黄霄汉,李继超.化痰祛瘀方治疗痰瘀互结型膝骨关节炎临床观察[J].光明中医,2021,36(4):563-565.
[7] 刘军,曾令烽,杨伟毅,等.基于中医大健康理念探讨膝骨关节炎循证分期及阶梯治疗[J].中华中医药杂志,2019,34(4):1321-1327.
[8] BIVER E,FRANCIS B,VALDES A M,et al.Gut microbiota and osteoarthritis management:an expert consensus of the European society for clinical and economic aspects of osteoporosis,osteoarthritis and musculoskeletal diseases(ESCEO)[J].Ageing Res Rev,2019,55:100946.
[9] ROBINSON W H,LEPUS C M,WANG Q,et al.Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis[J].Nat Rev Rheumatol,2016,12(10):580-592.
[10] 周鑫淼,叶超,李祥,等.膝骨关节炎不同证候关节液MMP-9、TIMP-1含量相关性研究[J].辽宁中医药大学学报,2020,22(6):108-111.
[11] 王悦,叶超,刘向春,等.膝关节骨性关节炎中医证型与外周血炎症指标的相关性研究[J].江苏中医药,2021,53(10):34-37.
[12] 叶超,陈婧,刘向春,等.不同证候膝骨关节炎患者证候程度评分与关节液炎性指标的典型相关分析[J].中国中医骨伤科杂志,2021,29(3):17-20.
[13] OSTOJIC M,ZEVRNJA A,VUKOJEVIC K,et al.Immunofluorescence analysis of NF-κB and iNOS expression in different cell populations during early and advanced knee osteoarthritis[J].Int J Mol Sci,2021,22(12):6461.
[14] ZHAO R,PENG X,LI Q,et al.Effects of phosphorylatable short peptide-conjugated chitosan-mediated IL-1Ra and IGF-1 gene transfer on articular cartilage defects in rabbits[J].PLoS One,2014,9(11):e112284.
[15] 侯德才.止骨增生合剂对兔膝骨关节炎治疗作用的实验研究[J].中华中医药学刊,2017,35(4):965-968.
[16] PELLETIER J P,MARTEL-PELLETIER J,ABRAMSON S B.Osteoarthritis,an inflammatory disease:potential implication for the selection of new therapeutic targets[J].Arthritis Rheum,2001,44(6):1237-1247.
[17] ZHANG Z,LI L,YANG W,et al.The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits[J].Osteoarthritis Cartilage,2017,25(2):309-320.
[18] BLUMENFELD I,GASPAR R,LAUFER D,et al.Enhancement of toluidine blue staining by transforming growth factor-β,insulin-like growth factor and growth hormone in the temporomandibular joint of aged mice[J].Cells Tissues Organs,2000,167(2/3):121-129.
[19] LIU S,DENG Z,CHEN K,et al.Cartilage tissue engineering:from proinflammatory and antiinflammatory cytokines to osteoarthritis treatments(Review)[J].Mol Med Rep,2022,25(3):99.
[20] 赵广,荆吉峰,张治宇,等.胰岛素样生长因子1促进创伤性关节炎软骨细胞的体外增殖[J].中国组织工程研究,2014,18(2):183-186.
[21] HOSSAIN M A,ADITHAN A,ALAM M J,et al.IGF-1 fcilitates cartilage reconstruction by regulating PI3K/Akt,MAPK,and NF-κB signaling in rabbit osteoarthritis[J].J Inflamm Res,2021,14:3555-3568.
[22] BANERJEE S,BIEHL A,GADINA M,et al.JAK-STAT signaling as a target for inflammatory and autoimmune diseases:current and future prospects[J].Drugs,2017,77(5):521-546.
[23] HU X,JI X,YANG M,et al.CDC42 is essential for both articular cartilage degeneration and subchondral bone deterioration in experimental osteoarthritis[J].J Bone Miner Res,2018,33(5):945-958.
[24] MALEMUD C J.Negative regulators of JAK/STAT signaling in rheumatoid arthritis and osteoarthritis[J].Int J Mol Sci,2017,18(3):484.
[25] YU H,LIU Z,ZHOU H,et al.JAK-STAT pathway modulates the roles of iNOS and COX-2 in the cytoprotection of early phase of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress[J].Neurosci Lett,2012,529(2):166-171.
[26] SHENG M,HUANG Z,PAN L,et al.SOCS2 exacerbates myocardial injury induced by ischemia/reperfusion in diabetic mice and H9C2 cells through inhibiting the JAK-STAT-IGF-1 pathway[J].Life Sci,2017,188:101-109.